Combined targeting of POSTN-integrin and MAPK/ERK signaling may play a synergistic role in inhibiting HCC growth and metastasis, as it simultaneously blocks upstream ECM-initiated signaling and downstream kinase cascades. Here, POSTN is linked to hepatocellular carcinoma.